Analysis of the RAS oncogene function by regulating the cellular RAS activity
Analysis of the RAS oncogene function by regulating the cellular RAS activity
批准号:
05807015
负责人:
OGISO Yoshifumi
金额:
$1.15万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for General Scientific Research (C)
财政年份:
1993
资助国家:
日本
项目状态:
已结题
起止时间:
1993 至 1994
中文摘要
我们已经发现H-ras突变体N116 Y对正常ras功能表现出显性负活性,并且能够抑制ras介导的信号通路。在这项研究中,我们证明,N116 Y抑制活性GTP结合形式的ras p21的生产。这表明N116 Y可能消耗鸟嘌呤核苷酸交换因子并破坏细胞ras功能。N116 Y对A431(外阴癌)、PC 3(前列腺癌)、T24(膀胱癌)、MCF 7(乳腺癌)、NKPS和TMK 1(胃癌)细胞系的增殖具有显著的抑制作用。为了检测N116 Y对A431和PC 3细胞的影响,我们将N116 Y基因转染A431细胞,并将其转染到PC 3细胞中。G418筛选后几乎所有的内斯都存活下来。结果表明,N116 Y基因在细胞内无明显表达,但在体内无致瘤性,细胞形态学改变,DNA断裂,提示N116 Y可能诱导细胞凋亡。因此,N116 Y可能适用于广泛的人类肿瘤的基因治疗。
英文摘要
We have already found that an H-ras mutant, N116Y,exhibited a dominant negative activity toward normal ras function and was capable of inhibiting the ras-mediated signaling pathways. In this study, we demonstrated that N116Y inhibited the production of the active GTP-bound form of ras p21s. This suggests that N116Y may consume the guanine nucleotide exchange factors and inactivate the cellular ras function.Next, we examined whether the N116Y mutant could suppress the growth of human tumor cells. N116Y extremely inhibited the proliferation of A431 (vulva), PC3 (prostate), T24 (bladder), MCF7 (breast), NKPS and TMK1 (stomach) cancer cell lines. A431 and PC3 cells were particularly susceptible to N116Y.In order to test the effects of N116Y on the neoplastic phenotypes, we transfected a less efficient N116Y expression vector into A431 cells. Almost all clo nes survived after G418 selection. However, they did not retain the N116Y gene and only one clone faintly expressed N116Y.This N116Y expressing clone had no tumorigenecity in vivo, and revealed deformed morphology and DNA fragmentation, suggesting that N116Y might have induced apoptotic cell death. Thus, N116Y may be applicable for gene therapy of a wide spectrum of human tumors.
期刊论文(29)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Sakai,N.: "Induction of apoptosis by dominant negative H-RAS mutant (116Y)in K562 cells." Experimental Cell Research. 215. 131-136 (1994)
Sakai,N.:“K562 细胞中显性失活 H-RAS 突变体 (116Y) 诱导细胞凋亡。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Ogiso, Y., Sakai, N., Watari, H., Yokoyama, T.and Kuzumaki, N.: "Suppression of various human tumor cell lines by a dominant negative H-ras mutant." Gene Therapy. 1. 403-407 (1994)
Ogiso, Y.、Sakai, N.、Watari, H.、Yokoyama, T. 和 Kuzumaki, N.:“显性失活 H-ras 突变体对各种人类肿瘤细胞系的抑制。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Ogiso,Y.: "Resistance of NIH3Y3 cells to v-fes transformation induced by a domonant negative H-ras mutant." Experimental Cell Research. 208. 415-421 (1993)
Ogiso,Y.:“NIH3Y3 细胞对显性阴性 H-ras 突变体诱导的 v-fes 转化的抵抗力。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Ogiso,Y.: "Resistance of NIH3T3 cells to v-fes transformation induced by a domonant negative H-ras mutant." Experimental Cell Research. 208. 415-421 (1993)
Ogiso,Y.:“NIH3T3 细胞对显性阴性 H-ras 突变体诱导的 v-fes 转化的抵抗力。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Shinohara,N.: "Differential Na^+,K^+-ATPase activity and cisplatin sensitivity between transformants induced by H-ras and those induced by K-ras." International Journal Cancer. 58. 672-677 (1994)
Shinohara,N.:“H-ras 诱导的转化体和 K-ras 诱导的转化体之间存在不同的 Na+,K+-ATP 酶活性和顺铂敏感性。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 13 条
Role of RAS oncogenes in a human chorionic cancer cell line.
-
批准号:07807024
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$1.15万
-
财政年份:1995
-
负责人:OGISO Yoshifumi
-
依托单位:
海外基金